Royal Agrifirm Group Acquires Hamlet Protein

Royal Agrifirm Group has reached an agreement to acquire Hamlet Protein, a global leader in specialty soy-based protein ingredients for young animal nutrition. The transaction is expected to close in the coming weeks. Hamlet Protein is well known for its highly digestible soy-based ingredients that promote gut health and consistent early-life performance. Its patented technology ensures reliable quality, which is crucial for feed manufacturers. The company employs around 115 people, operates production facilities in Denmark and the United States, and has a sales office in China.

For Royal Agrifirm Group, this acquisition strengthens its Specialties business, which provides high-value nutritional solutions and technical services to the feed industry. By integrating Hamlet Protein's capabilities with Agrifirm's nutritional expertise and global network, the combined organisation is better positioned to serve feed manufacturers and integrators worldwide. CEO Piet Hilarides explained that the acquisition aligns directly with the company's mission: "Hamlet Protein's proven technology strengthens our ability to help customers achieve optimal animal health and performance throughout the life cycle, driven by our shared focus on early feeding." Hamlet Protein CEO Erik Visser sees significant growth potential: "Joining Royal Agrifirm Group allows us to accelerate our development, expand our global reach and continue delivering high-digestibility solutions that support young animal health."

After closing, Hamlet Protein will continue to operate under its own name as part of Royal Agrifirm Group.

At Dutch Poultry Centre, we congratulate both teams on this milestone. This acquisition is a strong example of Dutch agricultural expertise expanding its global footprint through strategic partnerships, reinforcing the role of science-based innovation in building a more efficient and sustainable feed industry.

Royal Agrifirm Group, 31 March 2026